Aim of the Journal

The Journal of Rheumatology and Arthritis aims to serve as a comprehensive international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of rheumatology, arthritis, musculoskeletal medicine, and autoimmune disorders. The journal is dedicated to advancing scientific understanding of rheumatic and arthritic diseases, improving diagnostic methodologies, and promoting the development of innovative therapeutic and preventive strategies for inflammatory, degenerative, autoimmune, metabolic, and connective tissue disorders.

The journal seeks to bridge the gap between basic scientific research and clinical practice by encouraging translational and interdisciplinary studies that contribute to improved patient care, disease prevention, rehabilitation, and precision medicine in rheumatology. It promotes the dissemination of clinically relevant and scientifically rigorous findings that enhance the understanding of disease mechanisms, treatment outcomes, and long-term management of rheumatic conditions.

The journal also aims to foster collaboration among researchers, clinicians, rheumatologists, orthopedic specialists, immunologists, rehabilitation experts, academicians, and healthcare professionals worldwide. Emphasis is placed on scientific integrity, ethical research practices, evidence-based medicine, and the dissemination of knowledge that has significant clinical and societal impact.

Scope of the Journal

The journal covers a broad range of topics related to rheumatology, arthritis, autoimmune diseases, musculoskeletal disorders, connective tissue diseases, and therapeutic research. The primary areas of interest include, but are not limited to, the following:

Rheumatology, clinical rheumatology, pediatric rheumatology, autoimmune diseases, inflammatory arthritis, rheumatoid arthritis, osteoarthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, axial spondyloarthritis, reactive arthritis, crystal arthropathies, gout, pseudogout, lupus erythematosus, systemic lupus erythematosus, Sjögren’s syndrome, systemic sclerosis, scleroderma, vasculitis, dermatomyositis, polymyositis, mixed connective tissue disease, fibromyalgia, osteoporosis, osteopenia, metabolic bone diseases, musculoskeletal disorders, cartilage disorders, tendon disorders, ligament disorders, spinal disorders, chronic pain syndromes, connective tissue disorders, soft tissue rheumatism, autoimmune connective tissue diseases, inflammatory myopathies, bone and joint infections, septic arthritis, bursitis, synovitis, joint degeneration, musculoskeletal trauma, orthopedic rheumatology, rehabilitation medicine, sports rheumatology, geriatric rheumatology, occupational rheumatology, immunology in rheumatic diseases, inflammatory pathways, cytokine biology, molecular rheumatology, cellular immunology, immunogenetics, biomarkers in arthritis, autoimmune biomarkers, genetic susceptibility in rheumatic diseases, epigenetics in rheumatology, translational rheumatology, regenerative medicine, stem cell therapy, tissue engineering, biologics, biosimilars, monoclonal antibodies, targeted therapy, immunotherapy, disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroid therapy, pain management, physiotherapy, occupational therapy, rehabilitation strategies, joint replacement therapy, orthopedic surgery, minimally invasive procedures, arthroscopy, imaging in rheumatology, musculoskeletal ultrasound, MRI in arthritis, radiology of rheumatic diseases, diagnostic rheumatology, laboratory diagnostics, serological testing, autoimmune antibody testing, inflammatory markers, clinical trials, pharmacology, pharmacovigilance, personalized medicine, precision medicine, patient-centered care, quality of life studies, disability assessment, epidemiology of rheumatic diseases, public health rheumatology, community health, health disparities, healthcare access, nutrition and arthritis, lifestyle interventions, rehabilitation outcomes, complementary therapies, digital health in rheumatology, tele-rheumatology, artificial intelligence in rheumatology, bioinformatics, computational medicine, healthcare technologies, medical education in rheumatology, ethical issues in rheumatology, healthcare policy, patient safety, healthcare management, and emerging technologies in arthritis and musculoskeletal research.

Types of Manuscripts

The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, clinical studies, short communications, technical notes, perspectives, editorials, and letters to the editor.

The topics listed above represent the major areas of interest of the journal; however, the scope is not limited to these subjects alone. The journal welcomes submissions from emerging, interdisciplinary, and innovative areas that contribute to the understanding, diagnosis, prevention, management, and treatment of rheumatic and arthritic diseases.

Global Perspective and Inclusivity

The journal adopts a global perspective by encouraging submissions from researchers and clinicians across diverse geographic regions. Rheumatic and arthritic diseases affect populations worldwide, with variations in prevalence, risk factors, disease progression, and healthcare access influenced by genetic, environmental, occupational, and socio-economic factors.

By promoting international collaboration, the journal seeks to address global health challenges associated with musculoskeletal and autoimmune disorders while reducing disparities in diagnosis, treatment, and rehabilitation. Studies highlighting regional differences, population-specific findings, and public health approaches are particularly encouraged.

Ethical, Legal, and Social Considerations

Research in rheumatology and arthritis often involves important ethical, legal, and social considerations. The journal recognizes the significance of responsible clinical and scientific practices and encourages scholarly work addressing patient rights, informed consent, clinical ethics, data protection, healthcare equity, and access to advanced therapies.

Authors are expected to adhere to established ethical guidelines and ensure that their research respects the rights, dignity, and safety of patients and communities.

Education and Knowledge Dissemination

The journal is committed to advancing education and knowledge dissemination in the field of rheumatology and arthritis. It aims to serve as a valuable resource for students, educators, clinicians, researchers, rehabilitation specialists, and healthcare professionals by publishing high-quality, informative, and clinically relevant content.

Educational reviews, clinical updates, treatment guidelines, and evidence-based practice recommendations that simplify complex rheumatologic concepts and provide practical insights are encouraged.

Quality, Integrity, and Scientific Rigor

Maintaining high standards of quality and scientific integrity is a central principle of the journal. All submissions are expected to demonstrate methodological soundness, scientific rigor, originality, and clarity of presentation.

The peer review process is designed to ensure unbiased and thorough evaluation of manuscripts. Authors are encouraged to present their findings transparently and accurately, contributing to reliable and credible scientific literature in rheumatology and arthritis research.

Encouragement of Collaborative Research

The journal promotes collaborative and multidisciplinary research efforts involving rheumatologists, immunologists, orthopedic specialists, physiotherapists, rehabilitation experts, radiologists, molecular biologists, epidemiologists, and healthcare professionals.

Collaborative studies that integrate clinical practice, laboratory research, imaging technologies, rehabilitation sciences, and therapeutic innovations are highly encouraged to advance understanding and improve patient outcomes.

Adaptability to Advancing Science

The field of rheumatology is rapidly evolving with continuous advancements in immunology, biologic therapies, molecular medicine, imaging technologies, and personalized treatment approaches. The journal remains adaptable to these scientific developments by expanding its scope to include emerging research areas and innovative therapeutic strategies.

Authors are encouraged to explore novel concepts and contribute to the evolving landscape of rheumatology and arthritis research. The journal is committed to publishing content that reflects the latest scientific advancements and clinical innovations in the field.